Intrathecal baclofen for spasticity management: A comparative analysis of spasticity of spinal vs cortical origin

Journal of Spinal Cord Medicine

Volumn 33, Issue 1, 2010, Pages 16-21

  Saval, April ^a   Chiodo, Anthony E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Baclofen, intrathecal; Botulinum toxin type A; Brain injury, traumatic; Cerebral palsy; Intrathecal pump; Multiple sclerosis; Phenol; Spasticity, cortical, spinal; Spinal cord injuries; Stroke

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER REMOVAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; INFUSION PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SPASTICITY; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

EID: 77951833310     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2010.11689670     Document Type: Article

References (28)

1. Vender JR, Hughes M, Hughes BD, Hester S, Holsenback S, Rosson B. Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction. Neurosurg Focus. 2006;21(2):e6.
2. Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil. 1999;80(4):13-19. (Pubitemid 29035816)
3. Meythaler JM, Guin-Renfroe S, Hadley MN. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil. 1999;78(3):247-254. (Pubitemid 29227172)
4. Ridley B. Intrathecal baclofen therapy: challenges in patients with multiple sclerosis. Rehabil Nurs. 2006;31(4):158-164.
5. Smail BD, Peskine A, Roche N, Mailhan L, Thiebaut JB, Bussel B. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Mult Scler. 2006;12(1):101-103. (Pubitemid 43169244)
6. Hsieh JC, Penn RD. Intrathecal baclofen in the treatment of adult spasticity. Neurosurg Focus. 2006;21(2):e5.
7. Coffey RJ, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993;78(2):226-232. (Pubitemid 23039122)
8. Rawlins PK. Intrathecal baclofen therapy over 10 years. J Neurosci Nurs. 2004;36(6):322-327.
9. Katz RT. Management of spasticity. Am J Phys Med. 1988;67(3):108-116.
10. Brown P. Pathophysiology of spasticity, J Neurol Neurosurg Psychiatr. 1994;57(7):773-777.
11. Wahlquist GI. Evaluation and primary management of spasticity. Nurse Pract. 1987;12(3):27-32.
12. Knutsson E, Lindblom U, Martensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci. 1974;23(3):473-484.
13. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320(23):1517-1521. (Pubitemid 19145803)
14. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL. Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation. 2002;5(1):16-24. (Pubitemid 34127088)
15. Schiess M, Furr ES, Fisher S, Acosta F, Richard S, Izor R. Functional motor improvement in stroke related spastic hemiparesis after intrathecal baclofen pump therapy. Neurology. 2006;66:A324-A.
16. Francisco GE, Yablon SA, Schiess MC, Wiggs L, Cavalier S, Grissom S. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil. 2006;13(14):74-85. (Pubitemid 44748621)
17. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN, Francisco GE. Intrathecal baclofen for spastic hypertonia from stroke. Commentary. Stroke. 2001;32(9):2099-2109. (Pubitemid 32868106)
18. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil. 2001;82(2):155-161. (Pubitemid 32147882)
19. Korenkov AI, Niendorf WR, Darwish N, Glaeser E, Gaab MR. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries. Neurosurg Rev. 2002;25(4):228-230.
20. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil. 1996;77(1):35-39. (Pubitemid 26017489)
21. Francisco GE. Intrathecal baclofen therapy for stroke-related spasticity. Top Stroke Rehabil. 2001;8(1):36-46. (Pubitemid 32467178)
22. Francisco GE, Hu MM, Boake C, Ivanhoe CB. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj. 2005;19(5):359-364. (Pubitemid 40796424)
23. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Gussom SP. Intrathecal baclofen management of post-stroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil. 2006;87(11):1509-1515. (Pubitemid 44647181)
24. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin, J Neurosurg. 2003;98(2):291-295. (Pubitemid 36151022)
25. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin, J Neurol Neurosurg Psychiatr. 2004;75(11 ):1553-1557. (Pubitemid 39430606)
26. Nielsen JF, Hansen HJ, Sunde N, Christensen JJ. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin Neurol Neurosurg. 2002;104(2):142-145. (Pubitemid 34262654)
27. Akman MN, Loubser PG, Donovan WH, O'Neill ME, Rossi CD. Intrathecal baclofen: does tolerance occur? Paraplegia. 1993;31(8):516-520.
28. Boviatsis EJ, Kouyialis AT, Korfias S, Sakas DE. Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg. 2005;107(4):289-295. (Pubitemid 40693504)